Literature DB >> 23647957

Anti-inflammatory cytokines, pro-fibrogenic chemokines and persistence of acute HCV infection.

W O Osburn1, J S Levine, M A Chattergoon, D L Thomas, A L Cox.   

Abstract

Chemokines and cytokines play a vital role in directing and regulating immune responses to viral infections. Persistent hepatitis C virus (HCV) infection is characterized by the loss of anti-HCV cellular immune responses, while control of HCV infection is associated with maintenance of anti-HCV cellular immune responses. To determine whether plasma concentrations of 19 chemokines and cytokines controlling T-cell trafficking and function differed based on infection outcome, we compared them in at-risk subjects followed prospectively for HCV infection. Levels were compared over time in subjects who controlled HCV infection (Clearance) and subjects who developed persistent HCV infection (Persistence) at two time points during acute infection: (i) first viraemic sample (initial viraemia) and (ii) last viraemic sample in Clearance subjects and time-matched samples in Persistence subjects. At initial viraemia, increased pro-inflammatory tumour necrosis factor α (TNFα) plasma concentrations were observed in the Clearance group, while the plasma levels of anti-inflammatory interleukin (IL)-2, IL-10 and IL-13 were higher in the Persistence group. IL-13 was positively correlated with IL-2 and IL-10 at initial viraemia in the Persistence group. At the time of last viraemia, plasma levels of eotaxin, macrophage chemoattractant protein-4 (MCP-4), IL-5 and IL-10 were higher in the Persistence group and IL-10 and IL-5 levels were positively correlated. Collectively, these results suggest that the development of persistent infection is associated with an anti-inflammatory and pro-fibrogenic chemokine and cytokine profile that is evident at the onset of infection and maintained throughout acute infection.
© 2013 John Wiley & Sons Ltd.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23647957      PMCID: PMC3793396          DOI: 10.1111/jvh.12052

Source DB:  PubMed          Journal:  J Viral Hepat        ISSN: 1352-0504            Impact factor:   3.728


  31 in total

1.  Increased hepatitis C virus (HCV)-specific CD4+CD25+ regulatory T lymphocytes and reduced HCV-specific CD4+ T cell response in HCV-infected patients with normal versus abnormal alanine aminotransferase levels.

Authors:  F Bolacchi; A Sinistro; C Ciaprini; F Demin; M Capozzi; F C Carducci; C M J Drapeau; G Rocchi; A Bergamini
Journal:  Clin Exp Immunol       Date:  2006-05       Impact factor: 4.330

2.  Long-term interleukin 10 therapy in chronic hepatitis C patients has a proviral and anti-inflammatory effect.

Authors:  David R Nelson; Zhengkun Tu; Consuelo Soldevila-Pico; Manal Abdelmalek; Haizhen Zhu; Yi Ling Xu; Roniel Cabrera; Chen Liu; Gary L Davis
Journal:  Hepatology       Date:  2003-10       Impact factor: 17.425

3.  T cells with a CD4+CD25+ regulatory phenotype suppress in vitro proliferation of virus-specific CD8+ T cells during chronic hepatitis C virus infection.

Authors:  Tobias Boettler; Hans Christian Spangenberg; Christoph Neumann-Haefelin; Elisabeth Panther; Simonetta Urbani; Carlo Ferrari; Hubert E Blum; Fritz von Weizsäcker; Robert Thimme
Journal:  J Virol       Date:  2005-06       Impact factor: 5.103

4.  Identification and in vitro expansion of functional antigen-specific CD25+ FoxP3+ regulatory T cells in hepatitis C virus infection.

Authors:  Hirotoshi Ebinuma; Nobuhiro Nakamoto; Yun Li; David A Price; Emma Gostick; Bruce L Levine; J Tobias; William W Kwok; Kyong-Mi Chang
Journal:  J Virol       Date:  2008-03-12       Impact factor: 5.103

5.  Hepatitis C virus glycoproteins mediate pH-dependent cell entry of pseudotyped retroviral particles.

Authors:  Mayla Hsu; Jie Zhang; Mike Flint; Carine Logvinoff; Cecilia Cheng-Mayer; Charles M Rice; Jane A McKeating
Journal:  Proc Natl Acad Sci U S A       Date:  2003-05-21       Impact factor: 11.205

6.  Molecular cloning, nucleotide sequence, and expression of the gene encoding human eosinophil differentiation factor (interleukin 5).

Authors:  H D Campbell; W Q Tucker; Y Hort; M E Martinson; G Mayo; E J Clutterbuck; C J Sanderson; I G Young
Journal:  Proc Natl Acad Sci U S A       Date:  1987-10       Impact factor: 11.205

7.  IL-10 inhibits CD28 and ICOS costimulations of T cells via src homology 2 domain-containing protein tyrosine phosphatase 1.

Authors:  Alison Taylor; Mübeccel Akdis; Andrea Joss; Tunç Akkoç; Renate Wenig; Marco Colonna; Isabelle Daigle; Egbert Flory; Kurt Blaser; Cezmi A Akdis
Journal:  J Allergy Clin Immunol       Date:  2007-05-25       Impact factor: 10.793

8.  Up-regulated eotaxin plasma levels in chronic liver disease patients indicate hepatic inflammation, advanced fibrosis and adverse clinical course.

Authors:  Frank Tacke; Christian Trautwein; Eray Yagmur; Claus Hellerbrand; Reiner Wiest; David A Brenner; Bernd Schnabl
Journal:  J Gastroenterol Hepatol       Date:  2007-08       Impact factor: 4.029

9.  Diagnosis, management, and treatment of hepatitis C: an update.

Authors:  Marc G Ghany; Doris B Strader; David L Thomas; Leonard B Seeff
Journal:  Hepatology       Date:  2009-04       Impact factor: 17.425

10.  Selection pressure from neutralizing antibodies drives sequence evolution during acute infection with hepatitis C virus.

Authors:  Kimberly A Dowd; Dale M Netski; Xiao-Hong Wang; Andrea L Cox; Stuart C Ray
Journal:  Gastroenterology       Date:  2009-03-17       Impact factor: 22.682

View more
  12 in total

1.  Exploring Relationships Among Peripheral Amyloid Beta, Tau, Cytokines, Cognitive Function, and Psychosomatic Symptoms in Breast Cancer Survivors.

Authors:  Ashley Henneghan; Andreana P Haley; Shelli Kesler
Journal:  Biol Res Nurs       Date:  2019-11-10       Impact factor: 2.522

2.  Hepatitis C virus induces interleukin-1β (IL-1β)/IL-18 in circulatory and resident liver macrophages.

Authors:  Shubham Shrivastava; Anupam Mukherjee; Ranjit Ray; Ratna B Ray
Journal:  J Virol       Date:  2013-09-04       Impact factor: 5.103

Review 3.  Dynamic balance of pro- and anti-inflammatory signals controls disease and limits pathology.

Authors:  Joseph M Cicchese; Stephanie Evans; Caitlin Hult; Louis R Joslyn; Timothy Wessler; Jess A Millar; Simeone Marino; Nicholas A Cilfone; Joshua T Mattila; Jennifer J Linderman; Denise E Kirschner
Journal:  Immunol Rev       Date:  2018-09       Impact factor: 12.988

Review 4.  The fragile relationship between hepatitis C virus and its human host.

Authors:  Robert T Schooley
Journal:  Top Antivir Med       Date:  2014-01

5.  HIV infection is associated with higher levels of monocyte chemoattractant protein-1 and eotaxin among people with recent hepatitis C virus infection.

Authors:  François M J Lamoury; Behzad Hajarizadeh; Elizabeth Keoshkerian; Jordan J Feld; Janaki Amin; Suzy Teutsch; Gail V Matthews; Margaret Hellard; Gregory J Dore; Andrew R Lloyd; Tanya L Applegate; Jason Grebely
Journal:  BMC Infect Dis       Date:  2016-06-01       Impact factor: 3.090

6.  Hepatitis C Virus-Specific T Cell Receptor mRNA-Engineered Human T Cells: Impact of Antigen Specificity on Functional Properties.

Authors:  Anangi Balasiddaiah; Haleh Davanian; Soo Aleman; Anna Pasetto; Lars Frelin; Matti Sällberg; Volker Lohmann; Sarene Koh; Antonio Bertoletti; Margaret Chen
Journal:  J Virol       Date:  2017-04-13       Impact factor: 5.103

7.  A Cross-Sectional Exploration of Cytokine-Symptom Networks in Breast Cancer Survivors Using Network Analysis.

Authors:  Ashley Henneghan; Michelle L Wright; Garrett Bourne; Adam C Sales
Journal:  Can J Nurs Res       Date:  2020-06-01

8.  PSGL-1 on Leukocytes is a Critical Component of the Host Immune Response against Invasive Pneumococcal Disease.

Authors:  Elisa Ramos-Sevillano; Ana Urzainqui; Belén de Andrés; Rafael González-Tajuelo; Mirian Domenech; Fernando González-Camacho; Francisco Sánchez-Madrid; Jeremy S Brown; Ernesto García; Jose Yuste
Journal:  PLoS Pathog       Date:  2016-03-14       Impact factor: 6.823

9.  The effect of HIV infection and HCV viremia on inflammatory mediators and hepatic injury-The Women's Interagency HIV Study.

Authors:  Sheila M Keating; Jennifer L Dodge; Philip J Norris; John Heitman; Stephen J Gange; Audrey L French; Marshall J Glesby; Brian R Edlin; Patricia S Latham; Maria C Villacres; Ruth M Greenblatt; Marion G Peters
Journal:  PLoS One       Date:  2017-09-13       Impact factor: 3.240

Review 10.  Inflammatory and cardiovascular diseases biomarkers in chronic hepatitis C virus infection: A review.

Authors:  Ahmed Babiker; Mohamed Hassan; Safwan Muhammed; Gregory Taylor; Bhawna Poonia; Anoop Shah; Shashwatee Bagchi
Journal:  Clin Cardiol       Date:  2019-11-30       Impact factor: 2.882

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.